Conversations from CROI 2013: CDC’s Dr. John Ward

Content From: Ronald Valdiserri, M.D., M.P.H., Deputy Assistant Secretary for Health, Infectious Diseases, and Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human ServicesPublished: March 11, 20131 min read


Dr. John Ward
Viral hepatitis was among the topics receiving significant attention at the 2013 Conference on Retroviruses and Opportunistic InfectionsExit Disclaimer (CROI) in Atlanta this week. Sessions and posters explored a spectrum of topics ranging from virology to new frontiers in hepatitis treatments as well as examinations of HIV/HCV coinfection and its treatment.

Following his conference address, “Expanding the Individual and Public Health Benefits of Hepatitis C Virus TreatmentExit Disclaimer,” I sat down with my colleague Dr. John Ward, Director of CDC’s Division of Viral Hepatitis. We discussed viral hepatitis infection in the United States, new CDC recommendations about screening for the hepatitis C virus, and the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis.

Watch our conversation below:To read abstracts or view other presentations about viral hepatitis from CROI 2013, visit the conference websiteExit Disclaimer.